A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease
- First Posted Date
- 2008-05-09
- Last Posted Date
- 2016-09-27
- Lead Sponsor
- Medivation, Inc.
- Target Recruit Count
- 598
- Registration Number
- NCT00675623
A Study of the Novel Drug Dimebon in Patients With Huntington's Disease
- First Posted Date
- 2007-07-06
- Last Posted Date
- 2015-06-08
- Lead Sponsor
- Medivation, Inc.
- Target Recruit Count
- 91
- Registration Number
- NCT00497159
- Locations
- 🇺🇸
Huntington Study Group, Rochester, New York, United States
Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease
- First Posted Date
- 2006-10-12
- Last Posted Date
- 2008-01-04
- Lead Sponsor
- Medivation, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT00387270
- Locations
- 🇺🇸
Huntington Study Group, Rochester, New York, United States
Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
- First Posted Date
- 2006-09-18
- Last Posted Date
- 2015-11-11
- Lead Sponsor
- Medivation, Inc.
- Target Recruit Count
- 183
- Registration Number
- NCT00377715
- Locations
- 🇷🇺
Mental Health Research Center of Russian Academy of Medical Sciences, Moscow, Russian Federation
© Copyright 2025. All Rights Reserved by MedPath